Today in News History

On July 12, several notable moments in the history of News stand out. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1855, Pavel Nakhimov, Russian admiral (born 1802) passed away. In 1861, Anton Arensky, Russian pianist, composer, and educator (died 1906) was born. In 1881, Natalia Goncharova, Russian theatrical costume and set designer, painter and illustrator (died 1962) was born. In 1916, Lyudmila Pavlichenko, Ukrainian-Russian soldier and sniper (died 1974) was born. In 1920, The Soviet-Lithuanian Peace Treaty is signed, by which Soviet Russia recognizes the independence of Lithuania. In 1943, World War II: Battle of Kursk: German and Soviet forces engage in the Battle of Prokhorovka, one of the largest armored engagements of all time. In 1997, Malala Yousafzai, Pakistani-English activist, Nobel Prize laureate was born. In 1998, Arkady Ostashev, Soviet/Russian scientist and engineer (born 1925) passed away. In 2006, The 2006 Lebanon War begins. Together, these milestones provide historical context for today's news news and ongoing narratives.

Russia plans to complete clinical trials of tuberculosis vaccine by end of 2026

TASS

TASS

·

June 29, 2026

·

right

Scientists intend to register it in 2027, Irina Vasilyeva, Director of the National Medical Research Center for Phthisiopulmonology and Infectious Diseases, says

Narrative Intelligence Brief

This article was published by TASS, a source frequently categorized with a right bias based in Russia. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of TASS, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 50%

Center 17%

Right 33%


Off The Press

right

· Jul 2, 2026

Feds won’t explain plunge in people taking second dose of COVID vaccine

Speculation has been rife for five years about the surprisingly large number of Americans who skipped the second dose of an mRNA COVID-19 vaccine. Months into the jabs’ broad availability in 2021, the Centers for Disease Control and Prevention estimated five million people, or 8 of COVID vaccine recipients, had stopped with a single jab. []...Click to read more

Bloomberg

lean left

· Jul 4, 2026

Ebola Vaccine Trials Could Start This Year

As Ebola cases rise in Congo and Uganda, vaccine developers are accelerating efforts to combat the rare Bundibugyo strain. IAVI CEO Mark Feinberg says a candidate vaccine could enter human trials by year-end. (Source: Bloomberg)

Jezebel

left

· Jun 25, 2026

The Pentagon Lost Its War Against Flu Shots in Less than Two Months

Flu shots are mandatory once again, less than two months after being made optional, following a major military base outbreak.

The Eastern Herald

center

· Jul 2, 2026

Scientists Launch the First Drug Trial Against Congo’s Bundibugyo Ebola Outbreak

Researchers enrolled the first patient Thursday in Congo's Ituri province, testing remdesivir and MBP134 against the Bundibugyo Ebola strain that has infected more than 1,400 people and killed 438. Africa CDC is calling for 18 million to fund the full trial program.

Legal Insurrection

right

· Jun 27, 2026

Trump to Request Over $1.4 Billion in Ebola Funding from Congress

Meanwhile, two trials for the treatment of Bundibugyo Ebola will begin soon and France reports its first case. The post Trump to Request Over 1.4 Billion in Ebola Funding from Congress first appeared on Le·gal In·sur·rec·tion.

Syrian Arab News Agency

lean left

· Jul 5, 2026

Experimental DNA nasal vaccine shows promise against tuberculosis

Washington, July 5 (SANA) An experimental DNA-based nasal vaccine has shown promising results against tuberculosis (TB) in animal studies, raising hopes for a more effective treatment for one of the world’s deadliest infectious diseases. The vaccine, developed by researchers at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public []

Topics:

World · 3
Politics · 2
Business · 1

Related coverage for "Russia plans to complete clinical trials of tuberculosis vaccine by end of 2026": Off The Press — Feds won’t explain plunge in people taking second dose of COVID vaccine. Bloomberg — Ebola Vaccine Trials Could Start This Year. Jezebel — The Pentagon Lost Its War Against Flu Shots in Less than Two Months. The Eastern Herald — Scientists Launch the First Drug Trial Against Congo’s Bundibugyo Ebola Outbreak. Legal Insurrection — Trump to Request Over $1.4 Billion in Ebola Funding from Congress. Syrian Arab News Agency — Experimental DNA nasal vaccine shows promise against tuberculosis